Indeed, some studies have shown that B-cell lymphomas with concurrent MYC and BCL2 abnormalities, other than translocations, appear to behave similarly to MYC/BCL2 double-hit lymphomas [27–29]. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.